For the 2017-2019 allocation period, the Global Fund adopted a refined allocation methodology to deliver the aims of its 2017-2022 strategy and to increase the impact of country programs that prevent, treat and care for...
Which means that for the next allocation period, the Global Fund will proactively support sustainability and transition planning, especially for upper middle income countries (UMICs) and low middle income countries (LMICs) with low or moderate...
The youth toolkit for the High Level Meeting on HIV/AIDS (HLM) 2016 is developed by the PACT, a global coalition of youth organizations working collaboratively in the HIV response towards ensuring the health, well-being and...
Middle East and North Africa Position Statement on HIV/AIDS to the UN General Assembly Special Session High-Level Meeting on AIDS 6 – 8 June 2016 We, the undersigned communities of the MENA region; regional an...
Dear Director General Dr. Margaret Chan Request to include discussion of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines at the next WHO Board meeting As members of the Make Medicines...
At a time when the Kingdom of Morocco and the European Union are preparing to resume negotiations on the “comprehensive and thorough free trade agreement” (FTAA), Moroccan civil society unites to bell Alarm about ALECA’s...
The Global Fund in the MENA region The Global Fund against AIDS, Tuberculosis and Malaria (GFATM) is the largest financing institution that supports government and civil society in their response to HIV, TB and malaria...
Harare, December 1st, 2015 Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa united to urge ViiV Healthcare to allow affordable access to an...
ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients in...
The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for...
